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doi:10.1016/j.asjsur.2011.11.004Summary Background: Hyperparathyroid crisis is a rare, critical, and potentially fatal
disease. The aim of this study was to classify different clinical courses of this disease, accord-
ing to their preoperative medical responses and suggest the proper timing for surgery.
Methods: Patients who had undergone parathyroidectomies for hyperparathyroid crisis, were
enrolled between January 1, 1994 and January 31, 2009. Preoperative medical treatment
and responses in terms of predisposing factors, preoperative localization, operative and path-
ological findings, postoperative outcome, and intervals from medicine to surgery, were retro-
spectively reviewed.
Results: A total of 11 patients, receiving more than 72 hours of medical treatment, were
divided into three types by preoperative medical responses. These included: Type I (three
patients were resistant to medicine with persistent serum Ca > 14 mg/mL and were eventually
treated with emergency surgery; two died of postoperative respiratory and hepatic failure),
Type II (six patients with abnormal serum Ca < 14 mg/mL) and Type III (two patients in whom
serum calcium returned to normal preoperatively. One patient was successfully treated with
emergency surgery 18 hours post-hospitalization). We found no method for predicting the
medical response, but all Type I patients exhibited high serum Ca >14 mg/mL after 48 hours
of medical treatment. All abnormal parathyroid glands were >1.8 cm in length and easily
detectable using preoperative ultrasonography.
Conclusion: Because the response to pharmaceutical treatment of hyperparathyroid crisis is
unpredictable, relieving the patient’s dehydration is necessary first. Making a definiteof Surgery, College of Medicine and Hospital, National Cheng Kung University, Number 138, Shengli
3, Taiwan, ROC.
u.edu.tw (S.-M. Huang).
n Surgical Association. Published by Elsevier Taiwan LLC. All rights reserved.
148 H.-H. Yu et al.diagnosis and performing an early parathyroidectomy within 48 hours are then required, espe-
cially in patients exhibiting poor medical response.
Copyright ª 2011, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Hyperparathyroid crisis (also called “parathyroid crisis”) is
defined as hyperparathyroidism with a marked elevation of
parathyroid hormone (PTH), serum calcium >15 mg/dL,
and acute onset of severe signs and symptoms such as
dehydration, metal alteration, anorexia, vomiting, cardiac
dysfunction, ventricular arrhythmia, and impaired renal
function.1e3 Hyperparathyroid crisis is a rare disease with
rates ranging from 1.6% to 6% in patients having hyper-
parathyroidism,4 and is more frequently encountered in
persons over 40 years old than in younger patients.5,6 The
exact cause of hyperparathyroid crisis is unknown. Other
illnesses or forms of stress usually precipitate this disease,
but acute hemorrhage of the parathyroid gland may also
occur in the absence of any precipitating factors.7e11
Prompt surgical removal of the parathyroid glands is the
most basic and effective therapy for this potentially fatal
disease. However, before the 1980s, a definite diagnosis of
hyperparathyroid crisis was time consuming because of the
imperfect hormone assay and preoperative localization. In
addition, unstable vital signs caused primarily by dehydra-
tion, usually resulted in delayed surgery.1,12,13 For the past
two decades, calcitonin and bisphosphonate have been
widely used to treat hyperparathyroid crisis, but few
reports7 have discussed how these two drugs affect the
surgical approach. We retrospectively reviewed the records
of 12 patients with bisphosphonate-based treatment to
determine the proper timing for surgery.
2. Patients and methods
We retrospectively reviewed the medical records of patients
diagnosed with hyperparathyroid crisis between January 1,
1994 and January 31, 2009 at four hospitals in Taiwan
(National Cheng-Kung University Hospital, Buddhist Tzu-Chi
Hospital, Kaohsiung Veterans Hospital, and Kaohsiung
Medical University Hospital). We collected data regarding
age, gender, clinical presentation, consciousness level,
laboratory data such as serum intact PTH (iPTH), blood urea
nitrogen, calcium and phosphate levels, preoperative
medical treatment, ultrasonographic measurements of the
sizes of pathologic parathyroid glands, time to operation,
operative findings, pathology, and surgical complications
and outcome. Patients without intact medical information,
adequate resuscitation or monitoring of calcium levels were
excluded. Finally, data from 11 patients (five men and six
women; mean age: 67.9  4.3 years old; age range: 44e86
years old) were collected in this study.
The definition of hyperparathyroid crisis is severe hyper-
calcemia (>15 mg/dL) with associated acute symptoms and
signs. The patients received hypocalcemic management:
hydration, calcitonin, and bisphosphonate, with or withoutdiuretics. All patients received preoperative ultrasono-
graphic localization performed by two senior endocrine
surgeons. Three patients received Tc-99m-radiolabeled ses-
tamibi scans. Serial measurements of serum iPTH, calcium,
and phosphate were performed to evaluate medical
responses. All patients received parathyroidectomies.
Statistical analysis was performed using SPSS 12.0 for
Windows. The parameters of continuous variables are
means  standard error of the mean (SEM).3. Results
The patients’ initial mental conditions ranged from leth-
argy to semi-coma. The precipitating factors were diverse,
including the procedure of fine needle aspiration, aspira-
tion pneumonia, upper gastrointestinal bleeding, diabetes
mellitus with hyperglycemic hyperosmolar nonketotic
coma in two patients, urinary tract infection in two
patients (one with urosepsis) and upper respiratory infec-
tion, cardiac catheterization, and bone fractures in two
patients (humerus and femur) (Table 1). The highest
preoperative calcium levels were 17.2  0.9 mg/dL (range:
15.0 to 23.6 mg/dL). The iPTH levels were markedly
elevated and rose to 1439.8  218.3 pg/mL (range: 881 to
3372 pg/mL). Each patient was given adequate hydration,
a full dose of calcitonin, and bisphosphonate treatment,
and eight patients were also given diuretics.
Based on responses to preoperative medical therapies
and the serum Ca level on the operative day, we first clas-
sified 11 patients (numbers 1e11) receiving medical treat-
ment for more than 72 hours into three types (Figs. 1e3):
Type I (three patients, numbers 1e3): poormedical response
with serum Ca > 14.0 mg/dL; Type II (six patients, numbers
4e9): partial response with serum Ca >10.0 but <14.0 mg/
dL; and Type III (two patients, Numbers 10 and 11): favorable
response with serum Ca < 10.0 mg/dL. Two Type I patients
(numbers 1 and 3) were given hemodialysis. The three Type I
patients were resistant to medical treatments and were
given parathyroidectomies on post-admission on Days 4, 6,
and 13, respectively, after each had been diagnosed with
hyperparathyroid crisis. Two patients (numbers 2 and 3) died
from postoperative respiratory failure and hepatic failure.
In patient number 2, hypercalcemia induced nausea and
vomiting, resulting in aspiration pneumonia and further
respiratory failure; and in patient number 3, with a history of
chronic hepatitis C, dehydration led to hepatic failure. Two
Type III patients (numbers 10 and 11) responded favorably to
medical treatments. Their calcium levels fell from 15.0 mg/
dL and 15.4mg/dL to 9.8mg/dL and 9.6mg/dL on the 4th and
3rd days, respectively, and they were given elective para-
thyroidectomies on post-admission Days 6 (number 10) and
29 (number 11). Six patients (numbers 4e9) partially
responded to medical treatments; their calcium levels fell
Table 1 Clinical course and pathology of hyperparathyroid crisis in 12 patients. B Z bisphosphonate; Bo Z bone disease (osteoporosis, bone fracture); C Z calcitonin; D Z diuretics;
H Z hydration; R Z renal stone.
Patient/
age/sex
(Type)
iPTH
(pg/mL)
Initial
calcium
(mg/dL)
Calcium at 48 h
after medical
treatments
(mg/dL)
Calcium at 72 h
after medical
treatment
(mg/dL)
Pre-op
calcium
(mg/dL)
Medical
treatment
Interval
between
admission
and surgery
Precipitating
factors
Conscious
level
Tumor size
and pathology
(cm)
Outcome Image Renal disease
Bone disease
1/64 y/
female (I)
1140 20.1 16.5 15.8 16.0 H þ D þ C þ
B þ hemodylisis
6 d Fine needle
aspiration
Semicoma 4.0  2.0  1.0
Adenoma
Alive Echo R(-), B(-)
2/74 y /
female (I)
1186 17.0 15.2 14.8 14.5 H þ C þ
B þ hemodylisis
13 d Aspiration
pneumonia
Semicoma 3.5  2.5  1.0
2.0  1.5  1.5
Double
adenoma
Mortality Echo R(-), B(-)
3/80 y/
female (I)
881 15.4 14.9 15.1 15.0 H þ D þ C þ B 4 d upper
gastrointestinal
bleeding
Drowsy 2.1  1.0  0.4
Adenoma
Mortality Echo R(-), B(-)
4/82 y/
male (II)
910 16.4 12.7 12.7 10.4 H þ D þ C þ B 13 d Cardiac
catheterization
Lethargy 3  1.2  1.0
Adenoma
Alive Echo R(þ), B(þ)
5/50 y/
male (II)
1374 15.0 12.5 12.0 11.2 H þ D þ C þ B 12 d Tibia fracture Lethargy 2.0  1.0  0.5
Adenoma
Alive Echo R(þ)
6/44 y/
female (II)
3372 19.9 13.5 13.2 12.7 H þ D þ C þ B 10 d Femoral fracture Lethargy 2.5  0.7  0.7
Adenoma
Alive Echo þ
isotope
R(þ), B(þ)
7/54 y/
female (II)
1345 15.2 12.9 12.0 11.7 H þ C þ B 18 d Diabetes mellitus
with hyperglycemic
hyperosmolar
nonketotic coma
Lethargy 2.3  2.1  1.4
Adenoma
Alive Echo R(-), B(-)
8/73 y/
male (II)
1256 23.6 13.5 10.9 10.4 H þ D þ C þ B 23 d Upper respiratory
tract infection
Drowsy 1.8  1.5  1.0
Adenoma
Alive Echo R(-), B(-)
9/60 y/
male (II)
934 15.7 13.0 12.8 12.4 H þ D þ C þ B 28 d Urinary tract
infection
Drowsy 6.0  3 .2  3.0
Cancer
Alive Echo þ
isotope
R(-), B(-)
10/86 y/
female (III)
2108 15.0 13.0 10.8 9.0 H þ D þ C þ B 6 d Urosepsis Drowsy 7.2  4.8  2.2
Adenoma
Alive Echo R(-), B(þ)
11/80 y/
male (III)
1332 15.4 10.0 9.6 9.4 H þ C þ B 29 d Humeral fracture
and hepatitis
Drowsy 2.1  1.8  1.2
Adenoma
Alive EchoþIso R(-), B(þ)
12/54 y/
female
(early
surgery)
1042 16.0 d d 14.5 H þ C þ B 18 h Diabetes mellitus
with hyperglycemic
hyperosmolar
nonketotic coma
Lethargy 2.8  2.0  0.7
Adenoma
Alive Echo R(-), B(-)
H
yp
e
rp
a
ra
th
yro
id
crisis:
T
h
e
tim
in
g
o
f
su
rge
ry
149
Figure 1 Schematic representation of clinical course type
Idpoor medical response.
Figure 3 Schematic representation of clinical course type
IIIdgood medical response.
150 H.-H. Yu et al.from between 23.6 mg/dL and 15.0 mg/dL to between
10.4 mg/dL and 12.7 mg/dL. They were also given elective
parathyroidectomies post-admission between Days 10 and
28. All the calcium levels of Type II and III patients fell to less
than 13 mg/dL within the first 48 hours (Table 1). Therefore,
regarding the management of patient number 12, we per-
formed an early parathyroidectomy 18 hours post-
admission, after adequate hydration and a definite diag-
nosis of hyperparathyroid crisis using quick iPTH and neck
ultrasonography. The patient’s surgical outcome was favor-
able (Fig. 4).
The mean interval from conservative medical treatment
to surgery was 14.7  2.6 days (range: 18 to 29 days). All
the pathologic glands were >1.8 cm in diameter (mean:
3.32  0.54 cm; range: 1.8 to 7.2 cm). The pathology
reports revealed a solitary parathyroid adenoma in 10
patients, double adenomas in one patient, and parathyroid
carcinoma in one patient. No intraparathyroid hemorrhage
was discovered. All pathologic parathyroid glands were
identified using preoperative ultrasonography. Three
patients were given a Tc-99m-radiolabeled sestamibi scan
to confirm the localization.
4. Discussion
The time to definite diagnosis for hyperparathyroid crisis
is always pressing, but iPTH level results may be delayed
by routine institutional laboratory processes; therefore,
for patient number 12, a “quick” iPTH was recommended.Figure 2 Schematic representation of clinical course type
IIdpartial medical response.Because of the biological instability and short half-life (3e5
minutes) of iPTH, incorrect sample preservation may lead
to incorrect test results, or false lower values and delay the
diagnosis. It is necessary to obtain a blood sample in an
EDTA tube, preserve it at 2e8C, and then have it analyzed
as soon as possible.14,15
For the past 20 years, hydration, calcitonin, and
bisphosphonates, with or without furosemide, have been
used to treat hyperparathyroid crisis. Hydration therapy is
always the initial treatment for restoring volume depletion
and stabilizing the vital signs in patients with hyper-
parathyroid crisis. Usually, an adequate isotonic normal
saline supplement not only reverses the intravascular
hemoconcentration caused by hypercalcemia, but also
reduces the calcium level by approximately 1 to 2 mg/dL
within 24 hours.16 Furosemide decreases the reabsorption of
calcium in the renal tubules, induces calciuresis, and
prevents fluid overload when the intravascular volume
expands. However, overusing furosemide may induce dehy-
dration and increase calcium reabsorption. Since the 1980s,
calcitonin has been used to counteract the effects of PTH on
the kidneys and bones, but the treatment is effective for
only 72 hours.16,17 Bisphosphonate, which inhibits osteoclast
function, has been used to treat hyperparathyroid crisis
since the early 1990s. However, bisphosphonates have no
effect until 48 hours16,17 after they have been administered.
Bisphosphonate-based therapy was suggested as a bridge
to an elective parathyroidectomy by Phitayakorn andFigure 4 Scheme of clinical course of patient No.12.
Figure 5 Flowchart of recommended management of
hyperparathyroid crisis.
Hyperparathyroid crisis: The timing of surgery 151McHenry,7 when managing patients with hyperparathyroid
crisis. We discovered that bisphosphonate-based therapy
reduced serum calcium to normal levels in two patients
(Type III), which has never been reported in the literature.
However, three patients (Type I) were resistant to this
combination therapy and had iPTH levels at 1140, 1186, and
881 pg/mL, respectively. The iPTH levels of eight patients
(mean:691.7 pg/mL with five of them <500 pg/mL) in the
study of Phitayakorn and McHenry were much lower than
the iPTH levels of the patients in our study (mean:
1439.8 pg/mL). The severity seemed to be higher in our
series. In our series, systemic vital signs were stabilized
within 24 hours after rehydration, but the reduction of serum
calcium varied in each case. From our data, the medical
response appeared to be obvious after 48 hours of medical
treatment. All three poor response patients still had high
serum Ca >14 mg/mL after 48 hours, appearing not only
reluctant to hydration and calcitonin but also bisphosphonate
(serumcalcium>14mg/mLeven after 72 hours). By contrast,
the other eight patients (Types II and III) responded favorably
to medicine within 48 hours and afterwards (Table 1).
Neck eutopic solitary parathyroid adenoma is the most
common finding7e9 in hyperparathyroid crisis, and it was
discovered in 10/12 (81.8%) cases that we reviewed. Just as
in the cases reported in the literature, all the parathyroid
lesions in our series were >1.8 cm in length. A large lesion
is almost a routine finding in a hyperparathyroid crisis.
Those two characteristics facilitate localization using neck
ultrasonography. All our cases were detected using preop-
erative neck ultrasonography. Therefore, we recommended
that immediate neck ultrasonography should be routinely
used for hyperparathyroid crisis and a Tc-99m-radiolabeled
sestamibi scan should be used only to confirm or detect
possible ectopic lesions if neck ultrasonography is negative
or equivocal.
The mortality rate for hyperparathyroid crisis gradually
declined from 93% in 1956 to 0% in 20082,7,18 primarily
because of earlier diagnosis and improved medical inter-
ventions. Although parathyroidectomy is known to be the
most effective treatment for hyperparathyroid crisis, there
is no consensus about the timing of the parathyroidectomy
because of the difficultly comparing these rare cases.
Surgical intervention within 48 or 72 hours of admission has
been recommended.2 The technique of iPTH assay and the
waiting time for laboratory results were two barriers for an
early diagnosis within the first 24 hours after presentation.
The quick iPTH assay and high-frequency neck ultrasonog-
raphy have recently eliminated those barriers, however.
Some clinicians7 have recommended that surgery should be
delayed until the manifestations of hypercalcemia and
intravascular volume have been corrected. However, pro-
longed hypercalcemia crisis has been reported along with
possible lethal outcome and multiple organ failure.18e21
Two of our patients (74 years old and 80 years old), with
preoperatively poor medical response, developed post-
operative lethal complications. The semicoma patient
(number 2) suffered from severe nausea and vomiting,
resulting in aspiration pneumonia, and eventually died of
respiratory failure. Although patient number 3 received
parathyroidectomy on the 4th hospital day, high serum
calcium still aggravated the hepatitis C liver function,
resulting in hepatic failure. Based on our data, determiningthe factors for predicting response patterns to medical
treatment seemed difficult, but prolonged hypercalcemia,
old age and its comorbidity may lead to a lethal outcome.
Therefore, we believe that early surgical intervention
within 48 hours for the poor response patients is crucial for
lifesaving. Furthermore, we also advised early para-
thyroidectomy once the diagnosis was confirmed and the
vital signs became stable. For example, patient number 12
was successfully treated with early surgical intervention at
18 hours after admission. Fang et al suggested that high-risk
patients with hyperparathyroidism could be treated with
a minimally invasive (targeted) parathyroidectomy.22 The
operation can be easily applied in patients with hyper-
parathyroid crisis within a short time, because of the highly
successful rate of neck localization. Local anesthesia
combined with intraoperative quick iPTH was advocated in
recent outpatient practice for parathyroidectomy,23 and
we also recommend using this technique for hyper-
parathyroid crisis to avoid increasing the risk of cardiac
arrhythmia induced by hypercalcemia during general
anesthesia.24
In summary, we conclude that because the response of
hyperparathyroid crisis to conservative medical treatment
is unpredictable, early parathyroidectomy within 48 hours
(particularly for poor medical response patients) is highly
advised once the diagnosis and localization, as well as the
patients being sufficiently hydrated (Fig. 5), are complete.References
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